9.115  0.095 (1.05%)		09-17 14:16
Open: 9.06 High: 9.32 Volume: 10,304,701		Pre. Close: 9.02 Low: 9.03 Market Cap: 7,869(M)

Short term
Mid term
Targets	6-month :	11.81	1-year :	13.01
Resists	First :	10.11	Second :	11.14
Pivot price	9.01
Supports	First :	8.46	Second :	7.03
MAs	MA(5) :	8.98	MA(20) :	9.34
	MA(100) :	13.18	MA(250) :	18.33
MACD	MACD :	-0.6	Signal :	-0.7
%K %D	K(14,3) :	31.6	D(3) :	26.5
RSI	RSI(14): 39
52-week	High :	27.04	Low :	8.46

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ WBA ] has closed below upper band by 40.3%. Bollinger Bands are 63.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	9.31 - 9.36	9.36 - 9.41
Low:	8.74 - 8.8	8.8 - 8.85
Close:	8.94 - 9.03	9.03 - 9.11

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Tue, 17 Sep 2024
Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 7% Dividend Yields - Benzinga

Mon, 16 Sep 2024
Walgreens Boots Alliance (NASDAQ:WBA) Trading Down 1.6% - MarketBeat

Mon, 16 Sep 2024
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims - Benzinga

Sun, 15 Sep 2024
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Short Interest Up 15.2% in August - MarketBeat

Sat, 14 Sep 2024
Goldman Thinks Walgreens Boots Alliance, Inc. (WBA) Is A Long-Term AI Stock Set To Rally Eventually - Yahoo Finance

Fri, 13 Sep 2024
Walgreens paying $106.8 million to settle US prescription billing fraud charges - Reuters

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	863 (M)
Shares Float	714 (M)
Held by Insiders	17.4 (%)
Held by Institutions	61.5 (%)
Shares Short	82,910 (K)
Shares Short P.Month	66,330 (K)

EPS	-6.74
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	15.8
Profit Margin	-4 %
Operating Margin	0.3 %
Return on Assets (ttm)	1.2 %
Return on Equity (ttm)	-56 %
Qtrly Rev. Growth	2.5 %
Gross Profit (p.s.)	0
Sales Per Share	168.57
EBITDA (p.s.)	4.57
Qtrly Earnings Growth	191.5 %
Operating Cash Flow	725 (M)
Levered Free Cash Flow	2,170 (M)

PE Ratio	-1.36
PEG Ratio	-0.2
Price to Book value	0.57
Price to Sales	0.05
Price to Cash Flow	10.84

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.